The current situation in microbiome drug development

DOI
  • Kim Yun-Gi
    Research Center for Drug Discovery, Faculty of Pharmacy, Keio University

Bibliographic Information

Other Title
  • マイクロバイオーム創薬の現状

Abstract

In recent years, accumulating evidence indicates that dysbiosis of gut microbiota is associated with various diseases. In fact, restoring gut dysbiosis may lead to disease treatment, prevention, and alleviation of pathology. Therefore, many companies are being established worldwide to develop microbiome drugs that cure and prevent diseases by improving the gut environment (microbiome) . The development of microbiome drugs has received a great deal of interest over the past decade. Although there have been clinical and regulatory success stories, there have also been layoffs and bankruptcies at multiple microbiome companies for several reasons. In this section, I would like to discuss the development status of drug discovery focusing on the microbiome, including my own experiences.

Journal

  • MEDCHEM NEWS

    MEDCHEM NEWS 33 (4), 170-175, 2023-11-01

    The Pharmaceutical Society of Japan

Keywords

Details 詳細情報について

  • CRID
    1390579454815387392
  • DOI
    10.14894/medchem.33.4_170
  • ISSN
    24328626
    24328618
  • Text Lang
    ja
  • Data Source
    • JaLC
  • Abstract License Flag
    Disallowed

Report a problem

Back to top